microRNAs Are Key Regulators in Chronic Lung Disease: Exploring the Vital Link between Disease Progression and Lung Cancer

被引:7
|
作者
Eapen, Mathew Suji [1 ]
McAlinden, Kielan Darcy [1 ]
Myers, Stephen [1 ]
Lu, Wenying [1 ]
Sohal, Sukhwinder Singh [1 ]
机构
[1] Univ Tasmania, Sch Hlth Sci, Dept Lab Med, Resp Translat Res Grp, Launceston, Tas 7248, Australia
关键词
microRNA; COPD; lung cancer; EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200; FAMILY; FREE-RADICALS; EXPRESSION; SMOKING; BIOMARKERS; HISTOLOGY; BLOCKADE; SMOKERS; DAMAGE;
D O I
10.3390/jcm8111986
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
microRNAs (miRNAs) bind to mRNAs and inhibit their expression through post-transcriptionally regulating gene expression. Here, we elaborate upon the concise summary of the role of miRNAs in carcinogenesis with specific attention to precursor respiratory pathogenesis caused by cigarette smoke modulation of these miRNAs. We review how miRNAs are implicated in cigarette-smoke-driven mechanisms, such as epithelial to mesenchymal transition, autophagy modulation, and lung ageing, which are important in the development of chronic obstructive pulmonary disease and potential progression to lung cancer. Extracellular vesicles are key to inter-cellular communication and sharing of miRNAs. A deeper understanding of the role of miRNAs in chronic respiratory disease and their use as clinical biomarkers has great potential. Therapeutic targeting of miRNAs may significantly benefit the prevention of cancer progression.
引用
收藏
页数:6
相关论文
共 50 条
  • [11] MicroRNAs in inflammatory lung disease - master regulators or target practice?
    Oglesby, Irene K.
    McElvaney, Noel G.
    Greene, Catherine M.
    RESPIRATORY RESEARCH, 2010, 11
  • [12] Protein phosphatase 2A (PP2A): a key phosphatase in the progression of chronic obstructive pulmonary disease (COPD) to lung cancer
    Nader, Cassandra P.
    Cidem, Aylin
    Verrills, Nicole M.
    Ammit, Alaina J.
    RESPIRATORY RESEARCH, 2019, 20 (01)
  • [13] Common Mechanisms Linking Chronic Obstructive Pulmonary Disease and Lung Cancer
    Houghton, A. McGarry
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 : S273 - S277
  • [14] Genomic mechanisms of transformation from chronic obstructive pulmonary disease to lung cancer
    Wang, Diane C.
    Shi, Lin
    Zhu, Zhenhua
    Gao, Danyan
    Zhang, Yong
    SEMINARS IN CANCER BIOLOGY, 2017, 42 : 52 - 59
  • [15] Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer
    Szalontai, Klara
    Gemes, Nikolett
    Furak, Jozsef
    Varga, Tunde
    Neuperger, Patricia
    Balog, Jozsef A.
    Puskas, Laszlo G.
    Szebeni, Gabor J.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [16] MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
    Tang, Shengjie
    Li, Shuangjiang
    Liu, Tao
    He, Yiwei
    Hu, Haiyang
    Zhu, Yunhe
    Tang, Shoujun
    Zhou, Haining
    CANCER LETTERS, 2021, 502 : 71 - 83
  • [17] The role of microRNAs in lung cancer progression
    Zhang, Wen-Cheng
    Liu, Jinbo
    Xu, Xiangying
    Wang, Guangshun
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [18] The role of microRNAs in lung cancer progression
    Wen-Cheng Zhang
    Jinbo Liu
    Xiangying Xu
    Guangshun Wang
    Medical Oncology, 2013, 30
  • [19] Collagenolytic Matrix Metalloproteinases in Chronic Obstructive Lung Disease and Cancer
    Woode, Denzel
    Shiomi, Takayuki
    D'Armiento, Jeanine
    CANCERS, 2015, 7 (01): : 329 - 341
  • [20] MicroRNAs: a new key in lung cancer
    Yunlong Zhang
    Qian Yang
    Siwang Wang
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1105 - 1111